Geoffrey A Block Selected Research

Cinacalcet (Sensipar)

1/2018	Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis.
10/2017	Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
1/2017	Dosing of Etelcalcetide vs Cinacalcet for Secondary Hyperparathyroidism-Reply.
3/2016	Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.
1/2016	Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.
7/2015	Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
6/2015	Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
5/2015	The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
11/2014	Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
12/2013	The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geoffrey A Block Research Topics

Disease

33	Chronic Renal Insufficiency 01/2021 - 06/2007
31	Secondary Hyperparathyroidism 10/2020 - 11/2003
14	Hyperphosphatemia 10/2021 - 04/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 11/2003
10	Vascular Calcification 01/2022 - 11/2003
10	Heart Failure 01/2021 - 09/2007
9	Chronic Kidney Failure (Chronic Renal Failure) 05/2021 - 11/2003
8	Anemia 01/2021 - 01/2016
6	Hypoxia (Hypoxemia) 01/2021 - 01/2017
5	Myocardial Infarction 01/2021 - 09/2007
5	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2021 - 07/2008
5	Hypocalcemia 02/2020 - 02/2009
5	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2019 - 05/2015
4	COVID-19 03/2022 - 01/2021
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
4	Diarrhea 01/2019 - 01/2016
4	Kidney Diseases (Kidney Disease) 01/2018 - 02/2009
4	Hyperparathyroidism 03/2016 - 02/2009
4	Hypercalcemia (Milk Alkali Syndrome) 12/2013 - 04/2004
3	Infections 03/2022 - 01/2021
3	Inflammation (Inflammations) 12/2020 - 08/2008
3	Unstable Angina 01/2016 - 09/2007
2	Breakthrough Infections 03/2022 - 10/2021
2	Constipation 01/2022 - 06/2017
2	Stroke (Strokes) 01/2021 - 01/2021
2	Spasm (Spasms) 01/2019 - 10/2017
2	Vomiting 01/2019 - 10/2017
2	Proteinuria 01/2019 - 08/2016
2	Nausea 01/2019 - 10/2017
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2017 - 03/2014
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2016 - 07/2015
2	Sudden Death 01/2016 - 11/2014
2	Renal Insufficiency (Renal Failure) 07/2012 - 12/2007
2	Hypoparathyroidism 02/2009 - 11/2006
1	Hereditary Nephritis (Alport Syndrome) 01/2021
1	Albuminuria 10/2019
1	Hypophosphatemia 01/2019
1	Body Weight (Weight, Body) 12/2018
1	Weight Loss (Weight Reduction) 12/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Osteoporosis 01/2017
1	Bone Diseases (Bone Disease) 01/2017

Drug/Important Bio-Agent (IBA)

32	Phosphates (Orthophosphate)IBA 01/2022 - 07/2006
20	Cinacalcet (Sensipar)FDA Link 01/2018 - 11/2003
14	Parathyroid Hormone (Parathormone)IBA 10/2020 - 11/2003
14	MineralsIBA 01/2019 - 11/2003
13	CalciumIBA 07/2019 - 11/2003
10	Vitamin D FDA LinkGeneric 01/2020 - 11/2003
9	etelcalcetide hydrochlorideIBA 10/2020 - 01/2014
8	Hemoglobins (Hemoglobin)IBA 01/2021 - 05/2015
8	Fibroblast Growth Factor-23IBA 11/2020 - 07/2015
8	Phosphorus (Red Phosphorus)IBA 01/2017 - 11/2003
7	IronIBA 11/2019 - 03/2014
7	ferric citrateIBA 01/2019 - 03/2014
5	tenapanorIBA 10/2021 - 01/2016
5	bardoxolone methylIBA 01/2021 - 01/2018
4	HematinicsIBA 01/2021 - 01/2016
4	vadadustatIBA 01/2021 - 01/2019
4	Prolyl-Hydroxylase InhibitorsIBA 01/2021 - 01/2017
4	Erythropoietin FDA Link 01/2021 - 01/2017
4	SterolsIBA 12/2013 - 07/2008
3	VaccinesIBA 03/2022 - 01/2021
3	AlbuminsIBA 01/2021 - 06/2007
3	CreatinineIBA 01/2021 - 01/2018
3	Darbepoetin alfa (Aranesp)FDA Link 01/2021 - 01/2021
3	SodiumIBA 01/2018 - 01/2016
2	AntibodiesIBA 03/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 03/2022 - 10/2021
2	COVID-19 VaccinesIBA 03/2022 - 10/2021
2	Sevelamer (RenaGel)FDA Link 10/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2016
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2019
2	Sodium-Hydrogen ExchangersIBA 01/2019 - 01/2016
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2016
2	Dietary SodiumIBA 01/2018 - 08/2016
2	SaltsIBA 01/2018 - 11/2006
2	Peptides (Polypeptides)IBA 01/2015 - 01/2014
1	mRNA VaccinesIBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	Serum AlbuminIBA 05/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	EnzymesIBA 01/2021
1	TransferasesIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	AntioxidantsIBA 12/2020
1	calcium acetate (Phoslo)FDA LinkGeneric 01/2020
1	lanthanum carbonate (Fosrenol)FDA Link 01/2020
1	DioxygenasesIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	CholesterolIBA 01/2019
1	Inulin FDA Link 01/2018
1	HepcidinsIBA 01/2017

Therapy/Procedure

34	Renal Dialysis (Hemodialysis) 03/2022 - 04/2004
16	Therapeutics 01/2019 - 11/2003
3	Parathyroidectomy 01/2016 - 12/2013
1	Glycemic Control 12/2018
1	Kidney Transplantation 01/2018